AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Janna Nicole Schultzhaus

Examiner Janna Nicole Schultzhaus appears to be about average relative to their peer examiners. Their lifetime grant ratio is 19.5%, they average 3.28 office actions per granted patent, and their rejection profile leans toward §103 and meaningful §101 activity.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 3.28
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
6 years (2021-2026)
Phone
(571) 272-0812
Predicted Supervisor
N/A
Supervisor Phone
N/A
Tech Center
1600 - Biotechnology and Organic
Group
1680 - Nucleic Acid Assay and Combinatorial / Computational Chemistry

Metrics

Applications Evaluated
128
Granted Applications
25
Non-Granted Applications
103
Avg OA / Grant
3.28
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1631 , 1671 , 1685
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 19.5% 3.28
Art Unit 14 8.6% 2.77
Group 61 8.1% 2.37
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2021; examiner may not yet have been active in the available dataset.
2021 2 0 0.0%
2022 12 3 25.0%
2023 27 10 37.0%
2024 29 9 31.0%
2025 29 3 10.3%
2026 29 0 0.0%

25 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 114 4.4% 4.4% 57.0% 1.8%
2 84 16.7% 4.8% 50.0% 1.2%
3 61 29.5% 6.6% 39.3% 1.6%
4 47 34.0% 6.4% 36.2% 6.4%
5 24 50.0% 8.3% 25.0% 0.0%
6 12 66.7% 0.0% 25.0% 0.0%
7 6 66.7% 0.0% 33.3% 0.0%
8 2 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2021
2.8%
2022
26.0%
2023
34.4%
2024
27.9%
2025
6.9%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.